| abstract |
It is important to develop compounds that are useful as inhibitors of PKC-θ, given that the treatments currently available for most of the disorders associated with PKC-θ activation are inadequate. . The present invention relates to compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising the compounds and methods of using the compositions in the treatment of various diseases, conditions or disorders. The present invention also provides a method for preparing the compounds of the present invention. |